> top > projects > spacy-test > docs > PubMed:3926590 > annotations
spacy-test Home  

PubMed:3926590 JSONTXT 2 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
spaCy_T0 0-8 JJ denotes Systemic
spaCy_T1 9-18 NN denotes sclerosis
spaCy_T2 19-20 -LRB- denotes (
spaCy_T3 20-31 NN denotes scleroderma
spaCy_T4 31-32 -RRB- denotes )
spaCy_T5 33-36 CC denotes and
spaCy_T6 37-47 JJ denotes esophageal
spaCy_T7 48-62 NN denotes adenocarcinoma
spaCy_T8 62-63 : denotes :
spaCy_T9 64-66 VBZ denotes Is
spaCy_T10 67-76 VBN denotes increased
spaCy_T11 77-84 JJ denotes patient
spaCy_T12 85-94 NN denotes screening
spaCy_T13 95-104 JJ denotes necessary
spaCy_T14 104-105 . denotes ?
spaCy_T15 106-108 DT denotes An
spaCy_T16 109-118 VBN denotes increased
spaCy_T17 119-123 NN denotes risk
spaCy_T18 124-126 IN denotes of
spaCy_T19 127-137 NN denotes esophageal
spaCy_T20 138-147 NN denotes carcinoma
spaCy_T21 148-151 VBZ denotes has
spaCy_T22 152-156 VBN denotes been
spaCy_T23 157-165 VBN denotes reported
spaCy_T24 166-168 IN denotes in
spaCy_T25 169-177 JJ denotes systemic
spaCy_T26 178-187 NN denotes sclerosis
spaCy_T27 188-189 -LRB- denotes (
spaCy_T28 189-200 NN denotes scleroderma
spaCy_T29 200-201 -RRB- denotes )
spaCy_T30 201-202 . denotes .
spaCy_T31 203-211 JJ denotes Periodic
spaCy_T32 212-222 JJ denotes endoscopic
spaCy_T33 223-225 CC denotes or
spaCy_T34 226-236 JJ denotes radiologic
spaCy_T35 237-249 NN denotes surveillance
spaCy_T36 249-250 , denotes ,
spaCy_T37 251-253 CC denotes or
spaCy_T38 254-258 DT denotes both
spaCy_T39 258-259 , denotes ,
spaCy_T40 260-262 IN denotes of
spaCy_T41 263-271 JJ denotes systemic
spaCy_T42 272-281 NN denotes sclerosis
spaCy_T43 282-290 NNS denotes patients
spaCy_T44 291-295 IN denotes with
spaCy_T45 296-312 JJ denotes gastroesophageal
spaCy_T46 313-319 NN denotes reflux
spaCy_T47 320-328 NNS denotes symptoms
spaCy_T48 329-332 VBZ denotes has
spaCy_T49 333-337 VBN denotes been
spaCy_T50 338-349 VBN denotes recommended
spaCy_T51 350-353 IN denotes for
spaCy_T52 354-359 JJ denotes early
spaCy_T53 360-369 NN denotes detection
spaCy_T54 370-372 IN denotes of
spaCy_T55 373-380 NNP denotes Barrett
spaCy_T56 380-382 POS denotes 's
spaCy_T57 383-389 NN denotes mucosa
spaCy_T58 390-393 CC denotes and
spaCy_T59 394-404 NN denotes esophageal
spaCy_T60 405-419 NN denotes adenocarcinoma
spaCy_T61 419-420 . denotes .
spaCy_T62 421-422 DT denotes A
spaCy_T63 423-429 NN denotes review
spaCy_T64 430-432 IN denotes of
spaCy_T65 433-436 CD denotes 680
spaCy_T66 437-444 RB denotes closely
spaCy_T67 445-453 VBD denotes followed
spaCy_T68 454-462 JJ denotes systemic
spaCy_T69 463-472 NN denotes sclerosis
spaCy_T70 473-481 NNS denotes patients
spaCy_T71 482-485 IN denotes for
spaCy_T72 486-496 NN denotes esophageal
spaCy_T73 497-506 NN denotes carcinoma
spaCy_T74 507-509 IN denotes of
spaCy_T75 510-513 DT denotes all
spaCy_T76 514-519 NNS denotes types
spaCy_T77 519-520 , denotes ,
spaCy_T78 521-524 CC denotes and
spaCy_T79 525-527 IN denotes of
spaCy_T80 528-529 DT denotes a
spaCy_T81 530-535 JJ denotes 22-yr
spaCy_T82 536-546 NN denotes experience
spaCy_T83 547-551 IN denotes with
spaCy_T84 552-562 NN denotes esophageal
spaCy_T85 563-566 CC denotes and
spaCy_T86 567-582 JJ denotes esophagogastric
spaCy_T87 583-591 NN denotes junction
spaCy_T88 592-606 NN denotes adenocarcinoma
spaCy_T89 607-610 CC denotes and
spaCy_T90 611-627 JJ denotes undifferentiated
spaCy_T91 628-637 NN denotes carcinoma
spaCy_T92 637-638 , denotes ,
spaCy_T93 639-642 VBD denotes did
spaCy_T94 643-646 RB denotes not
spaCy_T95 647-653 VB denotes reveal
spaCy_T96 654-655 DT denotes a
spaCy_T97 656-667 JJ denotes significant
spaCy_T98 668-676 NN denotes increase
spaCy_T99 677-679 IN denotes in
spaCy_T100 680-683 DT denotes the
spaCy_T101 684-693 NN denotes frequency
spaCy_T102 694-696 IN denotes of
spaCy_T103 697-707 NN denotes esophageal
spaCy_T104 708-717 NN denotes carcinoma
spaCy_T105 718-720 IN denotes in
spaCy_T106 721-729 JJ denotes systemic
spaCy_T107 730-739 NN denotes sclerosis
spaCy_T108 739-740 . denotes .
spaCy_T109 741-748 JJ denotes Regular
spaCy_T110 749-761 NN denotes surveillance
spaCy_T111 762-765 IN denotes for
spaCy_T112 766-773 NNP denotes Barrett
spaCy_T113 773-775 POS denotes 's
spaCy_T114 776-785 NN denotes esophagus
spaCy_T115 786-789 CC denotes and
spaCy_T116 790-800 NN denotes esophageal
spaCy_T117 801-815 NN denotes adenocarcinoma
spaCy_T118 816-821 MD denotes would
spaCy_T119 822-825 RB denotes not
spaCy_T120 826-832 VB denotes appear
spaCy_T121 833-835 TO denotes to
spaCy_T122 836-838 VB denotes be
spaCy_T123 839-853 JJ denotes cost-effective
spaCy_T124 854-861 IN denotes because
spaCy_T125 862-864 IN denotes of
spaCy_T126 865-868 DT denotes the
spaCy_T127 869-875 NN denotes rarity
spaCy_T128 876-878 IN denotes of
spaCy_T129 879-888 NN denotes carcinoma
spaCy_T130 888-889 , denotes ,
spaCy_T131 890-899 VBD denotes increased
spaCy_T132 900-907 JJ denotes patient
spaCy_T133 908-918 NN denotes discomfort
spaCy_T134 919-922 CC denotes and
spaCy_T135 923-930 NN denotes expense
spaCy_T136 930-931 , denotes ,
spaCy_T137 932-935 CC denotes and
spaCy_T138 936-939 DT denotes the
spaCy_T139 940-952 JJ denotes questionable
spaCy_T140 953-960 NN denotes benefit
spaCy_T141 961-964 IN denotes for
spaCy_T142 965-974 JJ denotes long-term
spaCy_T143 975-983 NN denotes survival
spaCy_T144 983-984 . denotes .
spaCy_R0 spaCy_T0 spaCy_T1 amod Systemic,sclerosis
spaCy_R1 spaCy_T1 spaCy_T10 nsubjpass sclerosis,increased
spaCy_R10 spaCy_T10 spaCy_T10 ROOT increased,increased
spaCy_R100 spaCy_T100 spaCy_T101 det the,frequency
spaCy_R101 spaCy_T101 spaCy_T99 pobj frequency,in
spaCy_R102 spaCy_T102 spaCy_T101 prep of,frequency
spaCy_R103 spaCy_T103 spaCy_T104 amod esophageal,carcinoma
spaCy_R104 spaCy_T104 spaCy_T102 pobj carcinoma,of
spaCy_R105 spaCy_T105 spaCy_T104 prep in,carcinoma
spaCy_R106 spaCy_T106 spaCy_T107 amod systemic,sclerosis
spaCy_R107 spaCy_T107 spaCy_T105 pobj sclerosis,in
spaCy_R108 spaCy_T108 spaCy_T95 punct .,reveal
spaCy_R109 spaCy_T109 spaCy_T110 amod Regular,surveillance
spaCy_R11 spaCy_T11 spaCy_T12 amod patient,screening
spaCy_R110 spaCy_T110 spaCy_T120 nsubj surveillance,appear
spaCy_R111 spaCy_T111 spaCy_T110 prep for,surveillance
spaCy_R112 spaCy_T112 spaCy_T114 poss Barrett,esophagus
spaCy_R113 spaCy_T113 spaCy_T112 case 's,Barrett
spaCy_R114 spaCy_T114 spaCy_T111 pobj esophagus,for
spaCy_R115 spaCy_T115 spaCy_T114 cc and,esophagus
spaCy_R116 spaCy_T116 spaCy_T117 amod esophageal,adenocarcinoma
spaCy_R117 spaCy_T117 spaCy_T114 conj adenocarcinoma,esophagus
spaCy_R118 spaCy_T118 spaCy_T120 aux would,appear
spaCy_R119 spaCy_T119 spaCy_T120 neg not,appear
spaCy_R12 spaCy_T12 spaCy_T10 advcl screening,increased
spaCy_R120 spaCy_T120 spaCy_T131 ccomp appear,increased
spaCy_R121 spaCy_T121 spaCy_T122 aux to,be
spaCy_R122 spaCy_T122 spaCy_T120 xcomp be,appear
spaCy_R123 spaCy_T123 spaCy_T122 acomp cost-effective,be
spaCy_R124 spaCy_T124 spaCy_T120 prep because,appear
spaCy_R125 spaCy_T125 spaCy_T124 pcomp of,because
spaCy_R126 spaCy_T126 spaCy_T127 det the,rarity
spaCy_R127 spaCy_T127 spaCy_T124 pobj rarity,because
spaCy_R128 spaCy_T128 spaCy_T127 prep of,rarity
spaCy_R129 spaCy_T129 spaCy_T128 pobj carcinoma,of
spaCy_R13 spaCy_T13 spaCy_T10 oprd necessary,increased
spaCy_R130 spaCy_T130 spaCy_T131 punct ",",increased
spaCy_R131 spaCy_T131 spaCy_T131 ROOT increased,increased
spaCy_R132 spaCy_T132 spaCy_T133 amod patient,discomfort
spaCy_R133 spaCy_T133 spaCy_T131 dobj discomfort,increased
spaCy_R134 spaCy_T134 spaCy_T133 cc and,discomfort
spaCy_R135 spaCy_T135 spaCy_T133 conj expense,discomfort
spaCy_R136 spaCy_T136 spaCy_T131 punct ",",increased
spaCy_R137 spaCy_T137 spaCy_T131 cc and,increased
spaCy_R138 spaCy_T138 spaCy_T140 det the,benefit
spaCy_R139 spaCy_T139 spaCy_T140 amod questionable,benefit
spaCy_R14 spaCy_T14 spaCy_T10 punct ?,increased
spaCy_R140 spaCy_T140 spaCy_T131 conj benefit,increased
spaCy_R141 spaCy_T141 spaCy_T140 prep for,benefit
spaCy_R142 spaCy_T142 spaCy_T143 amod long-term,survival
spaCy_R143 spaCy_T143 spaCy_T141 pobj survival,for
spaCy_R144 spaCy_T144 spaCy_T131 punct .,increased
spaCy_R15 spaCy_T15 spaCy_T17 det An,risk
spaCy_R16 spaCy_T16 spaCy_T17 amod increased,risk
spaCy_R17 spaCy_T17 spaCy_T23 nsubjpass risk,reported
spaCy_R18 spaCy_T18 spaCy_T17 prep of,risk
spaCy_R19 spaCy_T19 spaCy_T20 amod esophageal,carcinoma
spaCy_R2 spaCy_T2 spaCy_T3 punct (,scleroderma
spaCy_R20 spaCy_T20 spaCy_T18 pobj carcinoma,of
spaCy_R21 spaCy_T21 spaCy_T23 aux has,reported
spaCy_R22 spaCy_T22 spaCy_T23 auxpass been,reported
spaCy_R23 spaCy_T23 spaCy_T23 ROOT reported,reported
spaCy_R24 spaCy_T24 spaCy_T23 prep in,reported
spaCy_R25 spaCy_T25 spaCy_T26 amod systemic,sclerosis
spaCy_R26 spaCy_T26 spaCy_T24 pobj sclerosis,in
spaCy_R27 spaCy_T27 spaCy_T26 punct (,sclerosis
spaCy_R28 spaCy_T28 spaCy_T26 appos scleroderma,sclerosis
spaCy_R29 spaCy_T29 spaCy_T26 punct ),sclerosis
spaCy_R3 spaCy_T3 spaCy_T1 appos scleroderma,sclerosis
spaCy_R30 spaCy_T30 spaCy_T23 punct .,reported
spaCy_R31 spaCy_T31 spaCy_T35 amod Periodic,surveillance
spaCy_R32 spaCy_T32 spaCy_T35 amod endoscopic,surveillance
spaCy_R33 spaCy_T33 spaCy_T32 cc or,endoscopic
spaCy_R34 spaCy_T34 spaCy_T32 conj radiologic,endoscopic
spaCy_R35 spaCy_T35 spaCy_T50 nsubjpass surveillance,recommended
spaCy_R36 spaCy_T36 spaCy_T35 punct ",",surveillance
spaCy_R37 spaCy_T37 spaCy_T35 cc or,surveillance
spaCy_R38 spaCy_T38 spaCy_T50 nsubjpass both,recommended
spaCy_R39 spaCy_T39 spaCy_T38 punct ",",both
spaCy_R4 spaCy_T4 spaCy_T1 punct ),sclerosis
spaCy_R40 spaCy_T40 spaCy_T38 prep of,both
spaCy_R41 spaCy_T41 spaCy_T43 amod systemic,patients
spaCy_R42 spaCy_T42 spaCy_T43 compound sclerosis,patients
spaCy_R43 spaCy_T43 spaCy_T40 pobj patients,of
spaCy_R44 spaCy_T44 spaCy_T43 prep with,patients
spaCy_R45 spaCy_T45 spaCy_T47 amod gastroesophageal,symptoms
spaCy_R46 spaCy_T46 spaCy_T47 compound reflux,symptoms
spaCy_R47 spaCy_T47 spaCy_T44 pobj symptoms,with
spaCy_R48 spaCy_T48 spaCy_T50 aux has,recommended
spaCy_R49 spaCy_T49 spaCy_T50 auxpass been,recommended
spaCy_R5 spaCy_T5 spaCy_T1 cc and,sclerosis
spaCy_R50 spaCy_T50 spaCy_T50 ROOT recommended,recommended
spaCy_R51 spaCy_T51 spaCy_T50 prep for,recommended
spaCy_R52 spaCy_T52 spaCy_T53 amod early,detection
spaCy_R53 spaCy_T53 spaCy_T51 pobj detection,for
spaCy_R54 spaCy_T54 spaCy_T53 prep of,detection
spaCy_R55 spaCy_T55 spaCy_T57 poss Barrett,mucosa
spaCy_R56 spaCy_T56 spaCy_T55 case 's,Barrett
spaCy_R57 spaCy_T57 spaCy_T54 pobj mucosa,of
spaCy_R58 spaCy_T58 spaCy_T57 cc and,mucosa
spaCy_R59 spaCy_T59 spaCy_T60 amod esophageal,adenocarcinoma
spaCy_R6 spaCy_T6 spaCy_T7 amod esophageal,adenocarcinoma
spaCy_R60 spaCy_T60 spaCy_T57 conj adenocarcinoma,mucosa
spaCy_R61 spaCy_T61 spaCy_T50 punct .,recommended
spaCy_R62 spaCy_T62 spaCy_T63 det A,review
spaCy_R63 spaCy_T63 spaCy_T67 nsubj review,followed
spaCy_R64 spaCy_T64 spaCy_T63 prep of,review
spaCy_R65 spaCy_T65 spaCy_T64 pobj 680,of
spaCy_R66 spaCy_T66 spaCy_T67 advmod closely,followed
spaCy_R67 spaCy_T67 spaCy_T67 ROOT followed,followed
spaCy_R68 spaCy_T68 spaCy_T70 amod systemic,patients
spaCy_R69 spaCy_T69 spaCy_T70 compound sclerosis,patients
spaCy_R7 spaCy_T7 spaCy_T1 conj adenocarcinoma,sclerosis
spaCy_R70 spaCy_T70 spaCy_T67 dobj patients,followed
spaCy_R71 spaCy_T71 spaCy_T70 prep for,patients
spaCy_R72 spaCy_T72 spaCy_T73 amod esophageal,carcinoma
spaCy_R73 spaCy_T73 spaCy_T71 pobj carcinoma,for
spaCy_R74 spaCy_T74 spaCy_T73 prep of,carcinoma
spaCy_R75 spaCy_T75 spaCy_T76 det all,types
spaCy_R76 spaCy_T76 spaCy_T74 pobj types,of
spaCy_R77 spaCy_T77 spaCy_T67 punct ",",followed
spaCy_R78 spaCy_T78 spaCy_T67 cc and,followed
spaCy_R79 spaCy_T79 spaCy_T78 prep of,and
spaCy_R8 spaCy_T8 spaCy_T7 punct :,adenocarcinoma
spaCy_R80 spaCy_T80 spaCy_T82 det a,experience
spaCy_R81 spaCy_T81 spaCy_T82 amod 22-yr,experience
spaCy_R82 spaCy_T82 spaCy_T79 pobj experience,of
spaCy_R83 spaCy_T83 spaCy_T82 prep with,experience
spaCy_R84 spaCy_T84 spaCy_T88 nmod esophageal,adenocarcinoma
spaCy_R85 spaCy_T85 spaCy_T84 cc and,esophageal
spaCy_R86 spaCy_T86 spaCy_T84 conj esophagogastric,esophageal
spaCy_R87 spaCy_T87 spaCy_T88 compound junction,adenocarcinoma
spaCy_R88 spaCy_T88 spaCy_T83 pobj adenocarcinoma,with
spaCy_R89 spaCy_T89 spaCy_T88 cc and,adenocarcinoma
spaCy_R9 spaCy_T9 spaCy_T10 auxpass Is,increased
spaCy_R90 spaCy_T90 spaCy_T91 amod undifferentiated,carcinoma
spaCy_R91 spaCy_T91 spaCy_T88 conj carcinoma,adenocarcinoma
spaCy_R92 spaCy_T92 spaCy_T95 punct ",",reveal
spaCy_R93 spaCy_T93 spaCy_T95 aux did,reveal
spaCy_R94 spaCy_T94 spaCy_T95 neg not,reveal
spaCy_R95 spaCy_T95 spaCy_T67 conj reveal,followed
spaCy_R96 spaCy_T96 spaCy_T98 det a,increase
spaCy_R97 spaCy_T97 spaCy_T98 amod significant,increase
spaCy_R98 spaCy_T98 spaCy_T95 dobj increase,reveal
spaCy_R99 spaCy_T99 spaCy_T98 prep in,increase